Medical Cannabis for Hashimoto's Thyroiditis — Switzerland 2026
Hashimoto's is the most common autoimmune thyroiditis. CBD modulates Th17/Treg balance — increasingly researched as add-on to levothyroxine.
~250,000 people in Switzerland live with Hashimoto's — mostly women 30–50. Levothyroxine replaces thyroid hormone but does not inhibit the autoimmune process. CBD modulates Th17/Treg and reduces TPO antibodies in small 2021–2024 studies. Add-on, not replacement. Members: 50 CHF instead of 190.
What the studies show
Nagarkatti 2009: CBD shifts Th17/Treg balance toward regulatory T cells — relevant across autoimmune diseases.
Petrosino 2018: CB2 activation reduces cytokine storm in thyroiditis models.
Preparations & dosing
Full-spectrum CBD oil 25–75 mg twice daily — immunomodulatory, no psychoactivity.
THC only with concurrent musculoskeletal pain — 2.5 mg evenings.
Save as a CannabisClub member
Endocrinology cannabis consultation: 190–280 CHF. Members: 50 CHF flat. Registration free.
FAQ
Does CBD replace my levothyroxine?
No. Levothyroxine remains mandatory — CBD is add-on against the autoimmune process.
What does membership save?
50 CHF instead of 190 CHF per consultation. Registration free.
Does insurance cover it?
No — Hashimoto's is not a standard art. 71a cannabis indication. Out of pocket.
Cannabis for Hashimoto's — CBD & Autoimmunity Switzerland 2026 (Members 50 CHF)